Women suffering from breast cancer often succumb to incurable recurrent disease resulting from therapy-resistant cancer cells. In this issue of Cancer Cell, Alvarez and colleagues identify downregulation of the tumor suppressor Par-4 as the key determinant in apoptosis evasion, which leads to tumor recurrence in breast cancer.
|Number of pages||3|
|State||Published - Jul 8 2013|
Bibliographical noteFunding Information:
This work was supported by a KLCR grant and NIH/NCI grant CA060872 (to V.M.R.).
ASJC Scopus subject areas
- Cell Biology
- Cancer Research